Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Prorok

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Gastroenterology & Hepatology|December 4, 2018
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trialEric A Miller, Paul F Pinsky, Robert E Schoen, et al.
Journal of the National Cancer Institute|February 10, 2015
Conceptualizing overdiagnosis in cancer screeningPamela M Marcus, Philip C Prorok, Anthony B Miller, et al.
Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.
Journal of the National Cancer Institute|September 13, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Journal of the National Cancer Institute|April 11, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Cancer|August 14, 2002
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialJoel L Weissfeld, Bruce S Ling, Robert E Schoen, et al.
Reviews on Recent Clinical Trials|April 10, 2018
Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening TrialPhilip C Prorok, Patrick Wright, Thomas R Riley, et al.
The Journal of Urology|February 16, 2005
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, Gerald L Andriole, Barnett S Kramer, et al.
Cancer|July 29, 2009
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung StudyV Paul Doria-Rose, Pamela M Marcus, Eva Szabo, et al.
Gynecologic Oncology|December 27, 2011
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancerJian-Lun Xu, John Commins, Edward Partridge, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Gastroenterology & Hepatology|December 4, 2018
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trialEric A Miller, Paul F Pinsky, Robert E Schoen, et al.
Journal of the National Cancer Institute|February 10, 2015
Conceptualizing overdiagnosis in cancer screeningPamela M Marcus, Philip C Prorok, Anthony B Miller, et al.
Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.
Journal of the National Cancer Institute|September 13, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Journal of the National Cancer Institute|April 11, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Cancer|August 14, 2002
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialJoel L Weissfeld, Bruce S Ling, Robert E Schoen, et al.
Reviews on Recent Clinical Trials|April 10, 2018
Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening TrialPhilip C Prorok, Patrick Wright, Thomas R Riley, et al.
The Journal of Urology|February 16, 2005
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, Gerald L Andriole, Barnett S Kramer, et al.
Cancer|July 29, 2009
Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung StudyV Paul Doria-Rose, Pamela M Marcus, Eva Szabo, et al.
Gynecologic Oncology|December 27, 2011
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancerJian-Lun Xu, John Commins, Edward Partridge, et al.
Pageof 9